Who are the key players in North America NGS-based RNA-sequencing Market industry?

The top 5 players are Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and PerkinElmer. These companies drive innovation through advanced sequencing platforms, sample preparation solutions, and comprehensive bioinformatics. Their extensive product portfolios, strong distribution networks, and continuous investments in R&D significantly influence the North American RNA-sequencing landscape.

What is the North America NGS-based RNA-sequencing Market growth?

The North America NGS-based RNA-sequencing market has experienced robust growth, primarily driven by rising R&D activities and adoption in clinical diagnostics. For example, Illumina reported double-digit revenue growth in 2023, fueled by expanding applications in transcriptomics, personalized medicine, and biomarker discovery among research and healthcare institutions.

Which segment accounted for the largest North America NGS-based RNA-sequencing Market share?

In 2023, the research and academic institutes segment held the largest market share, owing to increased government funding and large-scale genomic studies. These organizations utilize NGS-based RNA sequencing for basic research, disease characterization, and biomarker discovery, driving significant adoption across projects and collaborations.

What are the factors driving the North America NGS-based RNA-sequencing Market?

Key market drivers include technological advancements in sequencing, increasing transcriptomics-based research, and rising prevalence of genetic disorders. Companies like Thermo Fisher Scientific continue to launch high-throughput, cost-effective NGS solutions, enabling broader accessibility and accelerating the use of RNA-sequencing across diverse applications.

Which type accounted for the largest North America NGS-based RNA-sequencing Market share?

The largest market share by type belongs to the targeted RNA sequencing segment, favored for its cost efficiency and specificity in profiling defined gene sets. Targeted RNA-seq is extensively used in disease-focused research and diagnostics, offering improved sensitivity and faster data analysis compared to whole transcriptome sequencing.

Home Healthcare

North America NGS-based RNA-sequencing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America NGS-based RNA-sequencing Market: by Type (mRNA Sequencing, miRNA Sequencing, De novo Transcriptome Assembly, Small RNA Sequencing, Whole Transcriptome Sequencing, Targeted RNA Sequencing), Application (Diagnostics, Drug Discovery, Biomarker Discovery, Toxicogenomics, Personalized Medicine, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors & Resellers, Hospital Pharmacies, Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Pyrosequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20379

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1350
Regions	US, Canada, Mexico
Segments	By Type: mRNA Sequencing, miRNA Sequencing, De novo Transcriptome Assembly, Small RNA Sequencing, Whole Transcriptome Sequencing, Targeted RNA Sequencing; By Application: Diagnostics, Drug Discovery, Biomarker Discovery, Toxicogenomics, Personalized Medicine, Others
Players	Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, QIAGEN, BGI, PerkinElmer Inc., Pacific Biosciences, F. Hoffmann-La Roche AG, Lexogen GmbH, Takara Bio Inc., Oxford Nanopore Technologies, Arraystar Inc., NuGEN Technologies (TECAN Group), Eurofins Scientific, Macrogen Inc.

Frequently asked questions

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Study period:

2020-2035

Base year:

2026

Historical data

2020-2024

NO OF PAGE:

167

Customize This Report to Suit Your Requirements

Name

Bussiness Email

country

Phone number

Consulting Service

How Will You Befit From our consulting service

Get in touch with Us

US +91 89837 31618 (Tool Free)

sales [at] bussinessinsights.com

Market Segmentation

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1350
Regions	US, Canada, Mexico
Segments	By Type: mRNA Sequencing, miRNA Sequencing, De novo Transcriptome Assembly, Small RNA Sequencing, Whole Transcriptome Sequencing, Targeted RNA Sequencing; By Application: Diagnostics, Drug Discovery, Biomarker Discovery, Toxicogenomics, Personalized Medicine, Others
Players	Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, QIAGEN, BGI, PerkinElmer Inc., Pacific Biosciences, F. Hoffmann-La Roche AG, Lexogen GmbH, Takara Bio Inc., Oxford Nanopore Technologies, Arraystar Inc., NuGEN Technologies (TECAN Group), Eurofins Scientific, Macrogen Inc.